Viral Antigens Market Size & Growth | Report by 2027

Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Component (Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and Others); Technique (ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining, Immunofluorescence, and Others); and End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes); and Geography

  • Report Code : TIPRE00017334
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 200
Buy Now

The Viral Antigens market was valued at US$101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027.

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A viral antigen is a poison or toxic substance administered by these virulent entities, which induces immune reaction in its host. For instance, a viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.

Lucrative Regions in Viral Antigens Market

Lucrative Regions in Viral Antigens Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Increased Acceptance of Viral Antigens in Vaccine Development Fuels Market Growth

A viral antigen is a toxin or other substance released by a virus that is capable of inducing an immune response (to create an antibody) in the host organism. A viral protein is a viral genome-specified antigen that can be recognized by a specific immunological response. Vaccination aims to establish immunity in the host that, in the event of an infectious pathogen, will prevent illness. Therefore, in its simplest form, vaccine development for viral diseases involves the distribution of antigens that induce virus-specific neutralizing antibodies and avoid the induction of any off-target antibodies.

The development and use of vaccines has greatly reduced the number of illnesses and diseases over the years. The introduction of a variety of new types of vaccines has been made possible through the manipulation of DNA, RNA, proteins and sugars, increased knowledge of immune response, and a major leap in genetic engineering. Development of attenuated mutants, expression of possible antigens in live vectors, and purification and direct synthesis of antigens in new systems have significantly enhanced the vaccine technology.

Products Insights

In terms of component, the Coronavirus antigens segment held the largest share of the viral antigens market in 2019, and is expected to continue its dominance and register a higher the highest CAGR in the market during the forecast period.

Viral Antigens Market, by Component – 2019 and 2027

Viral Antigens Market, by Component – 2019 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Application Insights

Based on end user, the global viral antigens market is segmented into hospitals, clinics, laboratories, diagnostic centers, blood banks, and research institutes. The diagnostic centers segment held the largest share of the market in 2019, and the market for laboratories is expected to register grow at the highest CAGR during the forecast period.

A laboratory is a place where clinical specimen tests are conducted to collect information on the patient's health to help diagnose, treat, and prevent disease. Over the last few decades, there has been a significant revolution in viral diagnostic laboratories' services and their role in patients' clinical management. Laboratories differ in size and sophistication, providing a wide range of research facilities. More extensive services may be seen in Aacute care hospitals and medical centers might provide extensive services, where and 70% of clinical decisions are based on laboratory tests. Doctoral offices and clinics, and specialist nursing and long-term care facilities can have laboratories that offer more basic testing services. Accurate diagnosis of the virus requires laboratory examination of clinical specimens for the presence of viral antigens, viruses, or specific antibodies. Over the last few decades, there has been a significant revolution in viral diagnostic laboratories' service and their role in patients' clinical management.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Viral Antigens Market: Strategic Insights

viral-antigens-market
Market Size Value inUS$ 101.41 Million in 2019
Market Size Value byUS$ 236.80 Million by 2027
Growth rateCAGR of 11.0% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Players operating in the viral antigens market adopt collaboration and partnership strategies to meet demands of end users through the introduction of technologically advanced offerings, and these strategies  significantly support the growth of the market.

By Component

  • Influenza Viral Antigens
  • Coronavirus Antigens
  • Zika Virus Antigens
  • Ebola Virus Antigens
  • Dengue Virus Antigens
  • Herpes Simplex Virus (HSV) Viral Antigens
  • Rotavirus Viral Antigens
  • Hepatitis A-E Virus Antigens
  • Measles Virus Antigens
  • Mumps/Parotitis Virus Antigens
  • Others

By Technique

  • ELISA
  • Immunoassay
  • Hemagglutination
  • Radioimmunoassay (RIA)
  • Immunoperoxidase Staining
  • Immunofluorescence
  • Others

By End User

  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centers
  • Blood Banks
  • Research Institutes

By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Russia
  • Asia Pacific

    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa

    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America

    • Brazil
    • Argentina

Company Profiles

  • Microbix Biosystems
  • BIO-RAD LABORATORIES INC.
  • Creative Diagnostics
  • Aalto Bio Reagents Ltd.
  • Advanced Biotechnologies Inc.
  • Prospec-Tany Technogene Ltd.
  • ACROBiosystems.
  • MERIDIAN BIOSCIENCE, INC.
  • Rekom Biotech S.L
  • LGC Limited
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Component Antigens ; Technique ; and End User ; and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are the viral antigens?

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.

What are the driving factors for the viral antigens market across the globe?

The global viral antigens market is being driven by factors such increased acceptance of viral antigens in vaccine development and advancements in image analysis software and informatics platforms for viral antigen detection. Furthermore, emerging markets is likely to offer significant opportunities for the growth of the global viral antigens market.

What are the restraining factors for the viral antigens market across the globe?

The high cost of vaccine development is the significant factor that will hinder the viral antigens market growth.

The List of Companies - Viral Antigens Market

  1. Microbix Biosystems
  2. BIO-RAD LABORATORIES INC.
  3. Creative Diagnostics
  4. Aalto Bio Reagents Ltd.
  5. Advanced Biotechnologies Inc.
  6. Prospec-Tany Technogene Ltd.
  7. ACROBiosystems.
  8. MERIDIAN BIOSCIENCE, INC.
  9. Rekom Biotech S.L
  10.  LGC Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Viral Antigens Market